miR-16 is a tumor suppressor in progestin-induced breast cancer

被引：0
|
作者：
Venturutti, Leandro [1 ]
Rivas, Martin A. [1 ]
Schillaci, Roxana [1 ]
Huang, Tim H-M [2 ]
Elizalde, Patricia V. [1 ]
机构：
[1] Inst Biol & Med Expt, RA-1428 Buenos Aires, DF, Argentina
[2] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-2305
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2305
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development
    Rivas, Martin A.
    Venturutti, Leandro
    Huang, Yi-Wen
    Schillaci, Roxana
    Huang, Tim Hui-Ming
    Elizalde, Patricia V.
    BREAST CANCER RESEARCH, 2012, 14 (03)
  • [2] Downregulation of the tumor-suppressor miR-16 via progestin-mediated oncogenic signaling contributes to breast cancer development
    Martin A Rivas
    Leandro Venturutti
    Yi-Wen Huang
    Roxana Schillaci
    Tim Hui-Ming Huang
    Patricia V Elizalde
    Breast Cancer Research, 14
  • [3] Deregulation of tumor-suppressive miR-16 through progestin-mediated oncogenic signaling contributes to breast cancer development
    Rivas, Martin A.
    Huang, Yi-Wen
    Schillaci, Roxana
    Huang, Tim H-M
    Elizalde, Patricia V.
    CANCER RESEARCH, 2011, 71
  • [4] miR-16 enhances miR-302/367-induced reprogramming and tumor suppression in breast cancer cells
    Hoseinbeyki, Moslem
    Taha, Masoumeh F.
    Javeri, Arash
    IUBMB LIFE, 2020, 72 (05) : 1075 - 1086
  • [5] miR-16 is an in vivo suppressor of gastrointestinal tumorigenesis
    Moore, Ashleigh E.
    Young, Lisa E.
    Weller, Jan
    Meisner-Kober, Nicole
    Dixon, Dan A.
    CANCER RESEARCH, 2012, 72
  • [6] AP-1 and miR-16 underlie the differential response of breast cancer cells to tamoxifen upon progestin treatment
    Galigniana, N. M.
    Diaz Flaque, M. C.
    Venturutti, L.
    Mercogliano, M. F.
    De Martino, M.
    Izzo, F.
    Proietti, C. J.
    Elizalde, P. V.
    FEBS JOURNAL, 2014, 281 : 436 - 436
  • [7] Evaluation of miR-16 as an internal control in the patients with breast cancer
    Madadi, Soheil
    Soleimani, Meysam
    HUMAN PATHOLOGY, 2019, 85 : 329 - 329
  • [8] Prognostic significance of miR-16 in triple negative breast cancer
    Celik, S.
    Tuncel, T.
    Emirzeoglu, L.
    Berber, U.
    Ozgun, A.
    Bilgi, O.
    Karagoz, B.
    ANNALS OF ONCOLOGY, 2015, 26 : 29 - 29
  • [9] miR-16: A novel hereditary marker in breast cancer and their offspring
    Usmani, Ambreen
    Shoro, Amir Ali
    Shirazi, Bushra
    Memon, Zahida
    Hussain, Mehvish
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2017, 67 (03) : 446 - 450
  • [10] Progestin-induced caveolin-1 expression mediates breast cancer cell proliferation
    M Salatino
    W Beguelin
    M G Peters
    R Carnevale
    C J Proietti
    M D Galigniana
    C G Vedoy
    R Schillaci
    E H Charreau
    M C Sogayar
    P V Elizalde
    Oncogene, 2006, 25 : 7723 - 7739
12345